StockWatch
·
Other Pharmaceuticals
BuybackJun 30, 2026, 11:56 AM

Cosmos Health Authorizes $5M Share Repurchase Program

AI Summary

Cosmos Health Inc. announced that its Board of Directors has authorized a share repurchase program of up to $5 million of the company's common stock. The program is set to expire on December 31, 2026, and may be renewed at the company's discretion. CEO Greg Siokas expressed strong confidence in the company's operating fundamentals and growth prospects, noting that the repurchase program represents a significant portion of its market capitalization and an attractive opportunity to enhance shareholder value.

Key Highlights

  • Board authorized a share repurchase program of up to $5 million of common stock.
  • The program expires on December 31, 2026, with potential for renewal.
  • Repurchases will be made in the open market or through privately negotiated transactions.
  • CEO stated the program represents almost half of the company's market capitalization as of June 29, 2026.
  • CEO cited confidence in operating fundamentals, record revenue, and improving margins.